Chiesi USA Announces Key Promotions to Business Unit Leads

    NEXT STORY
    Outlook on the Biosimilars Global Market to 2026 – Patent Expirations of Major Biologics Leads Way for Biosimilars
    PREV STORY
    Merus Announces Pricing of Public Offering of Common Shares
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    How COVID-19 Impact on Hydroxychloroquine Market Report-Industry Share, Size, Growth, Trends, Top leader-Advanz Pharma, Teva Pharmaceutical Industries, Sanofi, Novartis AG, Lupin, Laurus Labs Ltd

    author_avatar
    NASDAQ Market News

    TLC Announces First Patient Enrollment in EXCELLENCE Trial Evaluating Single and Repeat Administrations of TLC599

    author_avatar
    NASDAQ Market News

    NewLink Genetics Presents Phase 1 Data Supporting Significantly Higher Exposure with Indoximod Prodrug, NLG802, and Biomarker Data from Two Phase 2 Trials Illustrating Indoximod’s Impact on the Tumor Microenvironment at SITC 2018

    AMES, Iowa, Nov. 09, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced that ...

    author_avatar
    NASDAQ Market News